금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
Stocks Rise Pre-Bell as Traders Await Fed Policy Decision, Inflation Report, Big Tech Earnings
The benchmark US stock measures pointed higher before the opening bell Monday as traders gear up for...
Stock market today: Dow, S&P 500, Nasdaq futures rise ahead of busy week of earnings, Fed rate decision
Investors braced for a full earnings docket and the Federal Reserve's next policy decision this week...
British Pound: Stronger PMIs lean hawkish for BoE – Danske Bank
Danske Research Team notes UK flash PMIs strengthened in October, with the composite rising to 53.1 ...
DOJ grand jury is said to probe allegations against UAW President Shawn Fain
You don’t have to be rich to be financially independent. Here’s how to take control of your money.
Relying on a high salary or a hot stock is a dangerous trap. Why the most secure people plan for sudden crisis.
Is the AI Bubble About to Burst?
Artificial intelligence is transforming business, but mounting evidence suggests its greatest value lies in supporting human expertise rather than replacing it.
Asian stock leadership shifts as AI-fueled rally shows signs of fatigue, SocGen says
Disney's 'Moana' cruises to No. 1 with $43M opening as Pixar, Minions hold strong
Eni CEO warns prolonged Middle East conflict could push oil prices higher
As five big U.S. banks report earnings on the same day, Citigroup is the one to watch
Among the largest U.S. banks, Citigroup is expected to show the greatest improvement by one important measure. But it still has a long way to go to reach its own performance target.
Iran bets Trump will blink first
Tehran takes high-stakes gamble with US over Strait of Hormuz
Britain Bets on Hydropower to Boost Energy Security
After years of neglect, the United Kingdom has big plans for hydropower as part of broader plans for a green transition. The government is supporting the development of three large-scale hydro-storage ...
Farage seeks political reset, finds himself running against man dressed as trash can
Many Investors Are Still Treating Gilead Sciences Like a Has-Been HIV Stock. 4 Drug Launches This Year Could Prove Them Wrong.
Gilead's expansion beyond HIV therapies will surprise many investors.
Which companies reporting earnings this week show the strongest bullish signals?